BiochemistrybioRxivPreprint
Dyslipidemic SPTLC3 Integrates Bile Acid-FXR Signaling with Sphingolipid Remodeling in MASLD
Michele Visentin, Zhibo Gai, Anna Kovilakath…·Museer A. Lone
This study identifies SPTLC3's role in integrating bile acid-FXR signaling with sphingolipid remodeling in MASLD, showing its dysregulation in human liver and association with disease.